Advertisement
Grifols, S.A.

Grifols, S.A. (GRFS) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

GRFSNASDAQ
HealthcareDrug Manufacturers - General
$7.32
$0.02(0.27%)
U.S. Market opens in 16h 27m
Advertisement

Grifols, S.A. (GRFS)

Meyka AI Score

Z

Key Financials

Market Cap6.2B
P/E Ratio10.42
EPS (TTM)$0.70
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$9.53
3 Months$10.86
1 Year Target$9.97

GRFS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GRFS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.42 and a market capitalization of 6.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.27%
5-Day Change
-4.19%
1-Month Change
-9.63%
3-Month Change
-10.73%
6-Month Change
-18.21%
Year-to-Date (YTD) Change
-21.71%
1-Year Change
-18.85%
3-Year Change
-17.01%
5-Year Change
-58.53%
All-Time (Max) Change
10.57%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

23,833 Employees
IPO DateJun 2, 2011
CountryES
Actively Trading

Frequently Asked Questions